Study of HS-10516 Combination Therapy in Patients With Advanced Renal Cell Carcinoma

Clinical trial NCT07097935 · RECRUITING

Trial details

NCT number: NCT07097935
Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Clear Cell Renal Cell Carcinoma

Start date: 2025-07-10
Primary completion: 2027-07-10
Enrollment: 104

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.